{"filing": {"accession": "0001477932-26-005809", "cik": "0001620704", "ticker": null, "company_name": "MED-X, INC.", "form_type": "S-1", "filing_type": "S-1", "filing_date": "2026-09-25", "accepted_datetime": null, "acceptance_datetime": null, "accepted_at": null, "primary_doc_url": "https://www.sec.gov/Archives/edgar/data/1620704/000147793226005809/0001477932-26-005809-index.htm", "filing_url": "https://www.sec.gov/Archives/edgar/data/1620704/000147793226005809/0001477932-26-005809-index.htm", "period_of_report": null}, "html_url": "/api/filings/000147793226005809/stream", "exhibits": [{"exhibit_number": "4.6", "exhibit_type": "4", "description": "Warrant to Purchase Shares of Common Stock, dated September 16, 2026, issued by Med-X, Inc. to Streeterville Capital, LLC", "filename": "medx_ex46.htm", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1620704/000147793226005809/medx_ex46.htm", "category": "debt", "incorporated_by_reference": false}, {"exhibit_number": "10.21", "exhibit_type": "10", "description": "Amendment to Promissory Note, dated August 1, 2023, between Med-X, Inc., Matthew Mills and Jennifer Mills", "filename": "medx_ex1021.htm", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1620704/000147793226005809/medx_ex1021.htm", "category": "contracts", "incorporated_by_reference": false}, {"exhibit_number": "10.22", "exhibit_type": "10", "description": "Third Amendment to Promissory Note and Line of Credit Agreement, dated September 8, 2026, between Med-X, Inc., Matthew Mills and Jennifer Mills", "filename": "medx_ex1022.htm", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1620704/000147793226005809/medx_ex1022.htm", "category": "debt", "incorporated_by_reference": false}, {"exhibit_number": "10.33", "exhibit_type": "10", "description": "Securities Purchase Agreement, dated September 16, 2026, between Med-X, Inc. and Streeterville Capital, LLC", "filename": "medx_ex1033.htm", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1620704/000147793226005809/medx_ex1033.htm", "category": "contracts", "incorporated_by_reference": false}, {"exhibit_number": "10.37", "exhibit_type": "10", "description": "Med-X, Inc. 2026 Stock Incentive Plan, effective January 2, 2026, and Form of Option Agreement", "filename": "medx_ex1037.htm", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1620704/000147793226005809/medx_ex1037.htm", "category": "contracts", "incorporated_by_reference": false}, {"exhibit_number": "10.38", "exhibit_type": "10", "description": "Second Amendment to Promissory Note, dated April 13, 2026, between Med-X, Inc., Matthew Mills and Jennifer Mills", "filename": "medx_ex1038.htm", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1620704/000147793226005809/medx_ex1038.htm", "category": "contracts", "incorporated_by_reference": false}, {"exhibit_number": "16.1", "exhibit_type": "16", "description": "LETTER", "filename": "medx_ex161.htm", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1620704/000147793226005809/medx_ex161.htm", "category": "other", "incorporated_by_reference": false}, {"exhibit_number": "23.1", "exhibit_type": "23", "description": "Consent of Cherry Bekaert LLP", "filename": "medx_ex231.htm", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1620704/000147793226005809/medx_ex231.htm", "category": "other", "incorporated_by_reference": false}, {"exhibit_number": "2.1", "exhibit_type": "2", "description": "Agreement of Merger and Plan of Reorganization by and among Med-X Acquisition Corp. and Pacific Shore Holdings, Inc. and Matthew Mills", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1620704/000147793217006230/medx_ex71.htm", "category": "plans", "incorporated_by_reference": true}, {"exhibit_number": "3.1", "exhibit_type": "3", "description": "Articles of Incorporation", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1620704/000147793215005601/medx_ex21.htm", "category": "incorporation", "incorporated_by_reference": true}, {"exhibit_number": "3.2", "exhibit_type": "3", "description": "Certificate of Designation of Series A Preferred Stock", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1620704/000147793222006725/medx_ex33.htm", "category": "incorporation", "incorporated_by_reference": true}, {"exhibit_number": "3.3", "exhibit_type": "3", "description": "Bylaws", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1620704/000147793215005601/medx_ex22.htm", "category": "incorporation", "incorporated_by_reference": true}, {"exhibit_number": "4.1", "exhibit_type": "4", "description": "Warrant to purchase shares of Med-X, Inc. Common Shares", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1620704/000147793221005273/medx_ex69.htm", "category": "debt", "incorporated_by_reference": true}, {"exhibit_number": "4.2", "exhibit_type": "4", "description": "Form of Common Stock Certificate of the Registrant", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1620704/000147793222006725/medx_ex41.htm", "category": "other", "incorporated_by_reference": true}, {"exhibit_number": "4.3", "exhibit_type": "4", "description": "Registration Rights Agreement", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1620704/000147793221005273/medx_ex610.htm", "category": "debt", "incorporated_by_reference": true}, {"exhibit_number": "4.4", "exhibit_type": "4", "description": "Promissory Note issued to Crestmark Bank dated November 27, 2012", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1620704/000147793222006725/medx_ex109.htm", "category": "debt", "incorporated_by_reference": true}, {"exhibit_number": "4.5", "exhibit_type": "4", "description": "Convertible Promissory Note between Med-X Inc and Joseph Winograde", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1620704/000147793223006987/medx_ex614.htm", "category": "debt", "incorporated_by_reference": true}, {"exhibit_number": "10.1", "exhibit_type": "10", "description": "Subscription Documents", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1620704/000147793215005601/medx_ex41.htm", "category": "contracts", "incorporated_by_reference": true}, {"exhibit_number": "10.2", "exhibit_type": "10", "description": "License Agreement, dated September 1, 2014, by and between Med-X, Inc., as the Licensee, and Pacific Shore Holdings, Inc. as the Licensor", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1620704/000147793215005601/medx_ex61.htm", "category": "contracts", "incorporated_by_reference": true}, {"exhibit_number": "10.3", "exhibit_type": "10", "description": "Posting Agreement, dated November 12, 2015, by and between Med-X, Inc. and StartEngine Crowdfunding, Inc., with Warrant attached.", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1620704/000147793215007483/medx_62.htm", "category": "debt", "incorporated_by_reference": true}, {"exhibit_number": "10.4", "exhibit_type": "10", "description": "Broker-Dealer Services Agreement with FundAmerica Securities, LLC", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1620704/000147793215007705/medx_ex63.htm", "category": "contracts", "incorporated_by_reference": true}, {"exhibit_number": "10.5", "exhibit_type": "10", "description": "Development, Marketing and Consulting Agreement with M6, dated June 20, 2016", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1620704/000147793216012593/medx1k_ex64.htm", "category": "contracts", "incorporated_by_reference": true}, {"exhibit_number": "10.6", "exhibit_type": "10", "description": "Agreement with Monarch Bay Securities, LLC", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1620704/000147793216012593/medx1k_ex65.htm", "category": "contracts", "incorporated_by_reference": true}, {"exhibit_number": "10.7", "exhibit_type": "10", "description": "Broker-Dealer Agreement executed March 3, 2021, between Med-X, Inc., and Dalmore Group, LLC", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1620704/000147793221001333/medx_ex67.htm", "category": "contracts", "incorporated_by_reference": true}, {"exhibit_number": "10.8", "exhibit_type": "10", "description": "Share Purchase Agreement by and among Med-X, Inc., GEM Global Yield LLC SCS and GEM Yield Bahamas Limited", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1620704/000147793221005273/medx_ex68.htm", "category": "contracts", "incorporated_by_reference": true}, {"exhibit_number": "10.9", "exhibit_type": "10", "description": "Med-X, Inc. 2016 Stock Incentive Plan", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1620704/000147793222006725/medx_ex1011.htm", "category": "contracts", "incorporated_by_reference": true}, {"exhibit_number": "10.13", "exhibit_type": "10", "description": "Lease between S&R Properties, Corp. and Pacific Shore Holdings, Inc. dated August 1, 2015", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1620704/000147793222006725/medx_ex105.htm", "category": "contracts", "incorporated_by_reference": true}, {"exhibit_number": "10.14", "exhibit_type": "10", "description": "Amendment to Lease with S&R Properties dated July 21, 2020", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1620704/000147793222006725/medx_ex106.htm", "category": "contracts", "incorporated_by_reference": true}, {"exhibit_number": "10.15", "exhibit_type": "10", "description": "Loan and Security Agreement between Crestmark Bank and Pacific Shore Holdings, Inc. dated November 27, 2012", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1620704/000147793222006725/medx_exh107.htm", "category": "debt", "incorporated_by_reference": true}, {"exhibit_number": "10.16", "exhibit_type": "10", "description": "Security Agreement Crestmark Bank and Pacific Shore Holdings, Inc.", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1620704/000147793222006725/medx_ex108.htm", "category": "contracts", "incorporated_by_reference": true}, {"exhibit_number": "10.17", "exhibit_type": "10", "description": "License Agreement between Matthew Mills and Pacific Shore Holdings, Inc. dated July 1, 2012", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1620704/000147793222007030/medx_ex1010.htm", "category": "contracts", "incorporated_by_reference": true}, {"exhibit_number": "10.18", "exhibit_type": "10", "description": "Licensing Agreement between Dr. Morton I. Hyson, M.D., PC. D.b.a. Hyson Medical Products and Pacific Shore Holdings, Inc. dated June 22, 2012", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1620704/000147793222007030/medx_ex1012.htm", "category": "contracts", "incorporated_by_reference": true}, {"exhibit_number": "10.19", "exhibit_type": "10", "description": "License Agreement between Matthew Mills and Pacific Shore Holdings, Inc. dated January 15, 2010", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1620704/000147793222006725/medx_ex1013.htm", "category": "contracts", "incorporated_by_reference": true}, {"exhibit_number": "10.20", "exhibit_type": "10", "description": "Line of Credit Agreement between Matthew Mills, Jennifer Mills, and Med-X, Inc., dated August 6, 2022", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1620704/000147793222005845/medx_ex611.htm", "category": "debt", "incorporated_by_reference": true}, {"exhibit_number": "10.23", "exhibit_type": "10", "description": "Agreement for the Purchase and Sale of Capital Stock between Med-X Inc and Joseph Winograde", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1620704/000147793223006987/medx_ex613.htm", "category": "contracts", "incorporated_by_reference": true}, {"exhibit_number": "10.24", "exhibit_type": "10", "description": "Purchaser\u2019s Rights Agreement between Med-X Inc and Joseph Winograde", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1620704/000147793223006987/medx_ex615.htm", "category": "contracts", "incorporated_by_reference": true}, {"exhibit_number": "10.25", "exhibit_type": "10", "description": "Amendment to the Agreement for the Purchase and Sale of Capital Stock, dated December 13, 2023, between Med-X, Inc. and Joseph Winograde", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1620704/000147793224000633/medx_ex1016.htm", "category": "contracts", "incorporated_by_reference": true}, {"exhibit_number": "10.26", "exhibit_type": "10", "description": "Purchaser\u2019s Rights Agreement, dated September 15, 2023", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1620704/000147793223007319/medx_ex1019.htm", "category": "contracts", "incorporated_by_reference": true}, {"exhibit_number": "10.27", "exhibit_type": "10", "description": "Distribution Agreement, dated September 25, 2023, between Med-X, Inc. and Ensystex Australasia Pty Ltd", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1620704/000147793223007319/medx_ex1020.htm", "category": "debt", "incorporated_by_reference": true}, {"exhibit_number": "10.28", "exhibit_type": "10", "description": "Form of Warrant Agency Agreement", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1620704/000147793224000633/medx_ex1020.htm", "category": "debt", "incorporated_by_reference": true}, {"exhibit_number": "10.29", "exhibit_type": "10", "description": "Amendment No. 1 to Agreement for the Purchase and Sale of Capital Stock between Med-X Inc and Joseph Winograde", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1620704/000147793224000633/medx_ex1021.htm", "category": "contracts", "incorporated_by_reference": true}, {"exhibit_number": "10.30", "exhibit_type": "10", "description": "Amendment No. 1 to the Convertible Promissory Note between Med-X Inc. and Joseph Winograde", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1620704/000147793224000633/medx_ex46.htm", "category": "contracts", "incorporated_by_reference": true}, {"exhibit_number": "10.31", "exhibit_type": "10", "description": "Engagement Agreement with Delbrook Digital Ltd., doing business as Bad Twin Capital", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1620704/000147793225006565/medx_ex68.htm", "category": "contracts", "incorporated_by_reference": true}, {"exhibit_number": "10.32", "exhibit_type": "10", "description": "Escrow Services Agreement with FundAmerica Securities, LLC", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1620704/000147793215007705/medx_ex81.htm", "category": "contracts", "incorporated_by_reference": true}, {"exhibit_number": "10.34", "exhibit_type": "10", "description": "Placement Agency Agreement, dated September 15, 2026, between Med-X, Inc. and Maxim Group LLC, filed as Exhibit 6.1 to the Company\u2019s Current Report on Form 1-U filed September 18, 2026", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1620704/000147793226005705/medx_61.htm", "category": "contracts", "incorporated_by_reference": true}, {"exhibit_number": "10.36", "exhibit_type": "10", "description": "Settlement Agreement and Mutual Release, dated August 26, 2026, by and among Med-X, Inc., GEM Global Yield LLC SCS and GEM Yield Bahamas Limited, filed as Exhibit 6.11 to the Company\u2019s Current Report on Form 1-U filed September 1, 2026", "filename": "", "edgar_url": "https://www.sec.gov/Archives/edgar/data/1620704/000147793226005338/medx_611.htm", "category": "contracts", "incorporated_by_reference": true}], "sections": [{"section_name": "part_2", "section_title": "Part II", "start_position": 582832, "end_position": 598550}], "tables": [{"table_index": 2, "table_type": "text", "caption": null, "header_text": "Nevada280046-5473113"}, {"table_index": 4, "table_type": "text", "caption": null, "header_text": "Large accelerated filer\u2610Accelerated filer\u2610"}, {"table_index": 9, "table_type": "text", "caption": null, "header_text": "Page"}, {"table_index": 13, "table_type": "text", "caption": null, "header_text": "\u00b7All-Purpose Insecticide: Marketed for use against common household and agricultural pests, including ants, cockroaches, and fleas."}, {"table_index": 15, "table_type": "text", "caption": null, "header_text": "\u00b7Thermal-Aid Zoo\u00ae: Child-friendly, animal-shaped heating and cooling packs."}, {"table_index": 17, "table_type": "text", "caption": null, "header_text": "\u00b7Berje: 42%"}, {"table_index": 18, "table_type": "text", "caption": null, "header_text": "\u00b7Berje: 50%"}, {"table_index": 25, "table_type": "text", "caption": null, "header_text": "CountryOfficial No.TitleCase StatusProperty Type"}, {"table_index": 27, "table_type": "text", "caption": null, "header_text": "CountryOfficial No.TitleCase StatusProperty Type"}, {"table_index": 30, "table_type": "text", "caption": null, "header_text": "\u00b7License application procedures;"}, {"table_index": 32, "table_type": "text", "caption": null, "header_text": "\u00b7Faster application processes;"}, {"table_index": 34, "table_type": "text", "caption": null, "header_text": "\u00b7Thermal-Aid: Exempt from FDA registration as it functions as a heating and cooling pack."}, {"table_index": 37, "table_type": "financial", "caption": null, "header_text": "For Three Months EndedJune 30(Unaudited)"}, {"table_index": 39, "table_type": "financial", "caption": null, "header_text": "For the Six Months Ended June 30,"}, {"table_index": 41, "table_type": "financial", "caption": null, "header_text": "Years Ended"}, {"table_index": 43, "table_type": "financial", "caption": null, "header_text": "\u00b7Our independent registered public accounting firm\u2019s report on our 2025 financial statements includes a going concern explanatory paragraph, and our conclusion that the substantial doubt has since bee"}, {"table_index": 45, "table_type": "text", "caption": null, "header_text": "\u00b7We may sustain losses that cannot be recovered through insurance or other preventative measures."}, {"table_index": 47, "table_type": "text", "caption": null, "header_text": "\u00b7Our results of operations may fluctuate from quarter to quarter for many reasons, including seasonality."}, {"table_index": 62, "table_type": "text", "caption": null, "header_text": "\u00b7We will not conduct a traditional \u201croadshow\u201d with underwriters prior to the opening of trading on Nasdaq. Instead, we intend to host an investor day, as well as engage in certain other investor educa"}, {"table_index": 65, "table_type": "text", "caption": null, "header_text": "\u00b7changes in the industries in which we operate;"}, {"table_index": 69, "table_type": "text", "caption": null, "header_text": "\u00b7actual or anticipated variations in our periodic operating results;"}, {"table_index": 75, "table_type": "financial", "caption": null, "header_text": "\u00b7our goal and strategies;"}, {"table_index": 79, "table_type": "text", "caption": null, "header_text": "ActualPro Forma As Adjusted(unaudited)"}, {"table_index": 82, "table_type": "text", "caption": null, "header_text": "1.International Expansion of Nature-Cide:In 2023, Med-X entered into a distribution agreement with Ensystex to expand Nature-Cide\u2019s reach into 29 international territories, including Australia, Southe"}, {"table_index": 84, "table_type": "text", "caption": null, "header_text": "4.Partnership with Dealmaker Securities:Med-X has engaged Dealmaker Securities LLC as the lead selling agent for its Regulation A offering. This partnership supports the company\u2019s efforts to reach a b"}, {"table_index": 86, "table_type": "financial", "caption": null, "header_text": "For Three Months EndedJune 30(Unaudited)"}, {"table_index": 88, "table_type": "financial", "caption": null, "header_text": "For the Six Months Ended June 30,"}, {"table_index": 89, "table_type": "financial", "caption": null, "header_text": "For Twelve Months Ended December 31,"}, {"table_index": 109, "table_type": "text", "caption": null, "header_text": "\u00b7Thermal-Aid Zoo\u00ae: Child-friendly, animal-shaped heating and cooling packs."}, {"table_index": 112, "table_type": "text", "caption": null, "header_text": "CountryOfficial No.TitleCase StatusProperty Type"}, {"table_index": 114, "table_type": "text", "caption": null, "header_text": "CountryOfficial No.TitleCase StatusProperty Type"}, {"table_index": 117, "table_type": "financial", "caption": null, "header_text": "1.Preventing the distribution of marijuana to minors;"}, {"table_index": 119, "table_type": "text", "caption": null, "header_text": "\u00b7License application procedures;"}, {"table_index": 120, "table_type": "text", "caption": null, "header_text": "\u00b7Faster application processes;"}, {"table_index": 124, "table_type": "text", "caption": null, "header_text": "NamePositionAgeTerm of Office"}, {"table_index": 125, "table_type": "text", "caption": null, "header_text": "(1)This person serves in the indicated position until the person resigns or is removed or replaced by a duly authorized action of the Board or the shareholders. This person has been in the indicated p"}, {"table_index": 129, "table_type": "text", "caption": null, "header_text": "\u00b7had a bankruptcy petition filed by or against any business of which such person was a general partner or executive officer either at the time of the bankruptcy or within two years prior to that time;"}, {"table_index": 133, "table_type": "text", "caption": null, "header_text": "(1)Risk-free interest rate - Risk-free interest rate was based on the US Treasury bond yield for a similar duration, as of the day of grant."}, {"table_index": 135, "table_type": "text", "caption": null, "header_text": "Name and Principal PositionYearSalary(1)($)Non-Equity Incentive Plan Compensation($)OptionAwards($)StockAwards($)Total ($)"}, {"table_index": 138, "table_type": "text", "caption": null, "header_text": "(1)Risk-free interest rate - Risk-free interest rate was based on the US Treasury bond yield for a similar duration, as of the day of grant."}, {"table_index": 142, "table_type": "text", "caption": null, "header_text": "\u00b7each of our directors and the named executive officers;"}, {"table_index": 144, "table_type": "text", "caption": null, "header_text": "Shares Beneficially OwnedPercentageShares ofClass A"}, {"table_index": 145, "table_type": "text", "caption": null, "header_text": "*Represents less than 1%."}, {"table_index": 147, "table_type": "text", "caption": null, "header_text": "Name of Beneficial OwnerVoting Shares ofCommonStockBeneficially OwnedShares ofSeries APreferredStockPercentage of Voting Sharesof Common Stock"}, {"table_index": 148, "table_type": "text", "caption": null, "header_text": "*Indicates beneficial ownership of less than 1%."}, {"table_index": 151, "table_type": "text", "caption": null, "header_text": "(1)Risk-free interest rate - Risk-free interest rate was based on the US Treasury bond yield for a similar duration, as of the day of grant."}, {"table_index": 153, "table_type": "text", "caption": null, "header_text": "\u00b7the combination was approved by the board of directors prior to the person becoming an interested stockholder or the transaction by which the person first became an interested stockholder was approve"}, {"table_index": 156, "table_type": "text", "caption": null, "header_text": "\u00b7any breach of their duty of loyalty to the corporation or its stockholders;"}, {"table_index": 158, "table_type": "text", "caption": null, "header_text": "\u00b71% of the number of shares of our common stock then outstanding; or"}, {"table_index": 160, "table_type": "financial", "caption": null, "header_text": "\u00b7an individual who is a citizen or resident of the United States;"}, {"table_index": 161, "table_type": "text", "caption": null, "header_text": "\u00b7a Non-U.S. Holder that is a financial institution, insurance company, tax-exempt organization, pension plan, broker, dealer or trader in securities, dealer in currencies, U.S. expatriate, controlled "}, {"table_index": 163, "table_type": "financial", "caption": null, "header_text": "\u00b7the gain is effectively connected with the Non-U.S. Holder\u2019s conduct of a trade or business in the United States (and, if required by an applicable income tax treaty, is attributable to a permanent e"}, {"table_index": 168, "table_type": "text", "caption": null, "header_text": "\u00b7Under clause (i), if the Current Reference Price is $10.00, then the maximum number of additional shares that can be matched is 200. If the Current Reference Price is $10.01, then the maximum number "}, {"table_index": 174, "table_type": "financial", "caption": null, "header_text": "Page"}, {"table_index": 177, "table_type": "financial", "caption": null, "header_text": "June 30,2026December 31,2025"}, {"table_index": 180, "table_type": "financial", "caption": null, "header_text": "For the Three Months EndedFor the Six Months Ended"}, {"table_index": 183, "table_type": "text", "caption": null, "header_text": "AdditionalTotal"}, {"table_index": 184, "table_type": "text", "caption": null, "header_text": "AdditionalTotal"}, {"table_index": 187, "table_type": "financial", "caption": null, "header_text": "For The Six Months Ended June 30,20262025"}, {"table_index": 198, "table_type": "text", "caption": null, "header_text": "June 30,2026December 31,2025"}, {"table_index": 199, "table_type": "financial", "caption": null, "header_text": "June 30,2026December 31,2025"}, {"table_index": 201, "table_type": "financial", "caption": null, "header_text": "June 30,2026December 31,2025"}, {"table_index": 202, "table_type": "text", "caption": null, "header_text": "June 30,2026December 31,2025"}, {"table_index": 204, "table_type": "text", "caption": null, "header_text": "For The Year Ended December 31,"}, {"table_index": 207, "table_type": "text", "caption": null, "header_text": "Summary of StockOptions Outstanding"}, {"table_index": 208, "table_type": "text", "caption": null, "header_text": "OptionsOutstandingWeightedAverageExercisePriceWeightedAverageGrant DateFair ValueAverageRemainingContractualLife (Years)"}, {"table_index": 210, "table_type": "text", "caption": null, "header_text": "Number ofAwardsWeighted Average ExerciseWeighted Average Contract Term"}, {"table_index": 214, "table_type": "financial", "caption": null, "header_text": "REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRMF-19"}, {"table_index": 218, "table_type": "financial", "caption": null, "header_text": "December 31,2025December 31,2024"}, {"table_index": 221, "table_type": "financial", "caption": null, "header_text": "For Years Ended December 31,20252024"}, {"table_index": 224, "table_type": "text", "caption": null, "header_text": "AdditionalTotalStockholders'"}, {"table_index": 227, "table_type": "financial", "caption": null, "header_text": "For Years Ended December 31,20252024"}, {"table_index": 232, "table_type": "text", "caption": null, "header_text": "CategoryUseful Life"}, {"table_index": 239, "table_type": "text", "caption": null, "header_text": "December 31,2025December 31,2024"}, {"table_index": 240, "table_type": "financial", "caption": null, "header_text": "December 31,2025December 31,2024"}, {"table_index": 241, "table_type": "financial", "caption": null, "header_text": "December 31,2025December 31,2024"}, {"table_index": 243, "table_type": "text", "caption": null, "header_text": "December 31,2025December 31,2024"}, {"table_index": 244, "table_type": "financial", "caption": null, "header_text": "December 31,2025December 31,2024"}, {"table_index": 247, "table_type": "text", "caption": null, "header_text": "2026$17,602"}, {"table_index": 248, "table_type": "text", "caption": null, "header_text": "For The Year Ended December 31,"}, {"table_index": 251, "table_type": "text", "caption": null, "header_text": "Number ofAwardsWeighted Average ExerciseWeighted Average Contractual Life"}, {"table_index": 253, "table_type": "text", "caption": null, "header_text": "Number ofAwardsWeighted Average ExerciseWeighted Average Contract Term"}, {"table_index": 255, "table_type": "financial", "caption": null, "header_text": "As Previously ReportedRestatement AdjustmentsAs Restated"}, {"table_index": 257, "table_type": "text", "caption": null, "header_text": "Year ended December 31DomesticForeign"}, {"table_index": 258, "table_type": "text", "caption": null, "header_text": "Year ended December 31FederalStateForeign"}, {"table_index": 259, "table_type": "financial", "caption": null, "header_text": "Reconciling item2025 (amount)2025 (%)2024 (amount)2024 (%)"}, {"table_index": 260, "table_type": "text", "caption": null, "header_text": "Deferred tax asset (liability)20252024"}, {"table_index": 262, "table_type": "text", "caption": null, "header_text": "Jurisdiction20252024"}, {"table_index": 265, "table_type": "financial", "caption": null, "header_text": "Amount"}, {"table_index": 267, "table_type": "text", "caption": null, "header_text": "YEAR(1)OFFERINGSHARES SOLDNET PROCEEDS"}, {"table_index": 270, "table_type": "exhibit_index", "caption": null, "header_text": "Exhibit No.Description"}, {"table_index": 290, "table_type": "text", "caption": null, "header_text": "Med-X, Inc."}, {"table_index": 291, "table_type": "text", "caption": null, "header_text": "SIGNATURETITLEDATE"}], "exhibits_pending": false, "cdn_html": null, "response_time_ms": 846}